Comparative efficacy of subcutaneous versus oral methotrexate in active rheumatoid arthritis.

医学 类风湿性关节炎 内科学 甲氨蝶呤 恶心 痹症科 不利影响 关节炎 呕吐 皮下注射 胃肠病学 B组
作者
M S Islam,Syed Atiqul Haq,Md Monirul Islam,Abul Kalam Azad,M A Islam,Rajib Barua,Md. Mehedi Hasan,Muhammad Muzaffar Mahmood,Md. Safiuddin,M M Rahman,M F Osmany,N Bari,R S Rumki,Farah Rashid
出处
期刊:PubMed 卷期号:22 (3): 483-8 被引量:11
链接
标识
摘要

This prospective study was conducted in rheumatology clinic under the department of medicine of Bangabandhu Sheikh Mujib Medical University from December 2004 to December 2005 to asses the efficacy, safety and compliance of subcutaneous methotrexate (MTX) in active rheumatoid arthritis (RA) patients. A total of 92 active rheumatoid arthritis patients according to American College of Rheumatology (ACR) criteria were recruited for the trial for six months. Among them 46 cases belonged to injectable MTX group and 46 cases belonged to oral MTX group. Mean±SD age of patients was 45.54±12.42 vs. 44.63±13.99 years in subcutaneous group and oral group respectively. In the subcutaneous group 41 were female and 5 male; in the oral group 34 were female and 12 male. Mean duration of the disease was 49.74 months in subcutaneous group and 49 months in oral group. RA test was positive in 35 cases in both groups whereas Rose Waaler test was positive in 19 patients in subcutaneous group and 14 patients in oral group. At 24 week, response rate of ACR 20 was significantly higher in subcutaneous MTX than oral MTX group (93% vs. 80%, p=0.02). Similarly ACR 50 response was significantly higher in subcutaneous MTX than in oral group (89% vs. 72%, p=0.03). ACR 70 response was not significantly higher in SCMTX group then oral group (11% vs. 9 %, p=0.72). Adverse effects were relatively less in subcutaneous MTX and most common side effects were nausea (37% vs. 63%), vomiting (11% vs. 30%), dyspepsia (29% vs. 48%), dizziness (4l% vs. 52%) and alopecia (72% vs. 85%). The results of the study demonstrated that subcutaneous MTX was significantly more effective than oral MTX at the same dosage in active Rheumatoid arthritis patients with no increase in side effects.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
烟花应助科研通管家采纳,获得10
刚刚
慕青应助科研通管家采纳,获得10
刚刚
馒头爸爸完成签到,获得积分10
刚刚
情怀应助科研通管家采纳,获得10
刚刚
所所应助科研通管家采纳,获得10
刚刚
yar应助科研通管家采纳,获得10
1秒前
ding应助科研通管家采纳,获得10
1秒前
米奇发布了新的文献求助10
1秒前
1秒前
1秒前
NexusExplorer应助科研通管家采纳,获得10
1秒前
yar应助科研通管家采纳,获得10
1秒前
Timothy完成签到 ,获得积分10
1秒前
1秒前
无花果应助科研通管家采纳,获得10
1秒前
研友_VZG7GZ应助科研通管家采纳,获得10
1秒前
2秒前
豆沙卷发布了新的文献求助10
2秒前
2秒前
小二郎应助温暖寻雪采纳,获得10
5秒前
暮夏钟鼓发布了新的文献求助10
5秒前
lironghao发布了新的文献求助10
5秒前
小温发布了新的文献求助10
5秒前
5秒前
6秒前
sissiarno应助贪玩海之采纳,获得30
7秒前
飘逸访文完成签到,获得积分10
7秒前
阿奎罗发布了新的文献求助30
7秒前
yyuu发布了新的文献求助10
8秒前
香蕉觅云应助豆沙卷采纳,获得10
9秒前
小北发布了新的文献求助10
9秒前
斯文败类应助熊熊大火采纳,获得20
10秒前
科目三应助1111chen采纳,获得10
10秒前
米奇完成签到,获得积分10
10秒前
Lin完成签到,获得积分10
11秒前
斯文败类应助暮夏钟鼓采纳,获得10
11秒前
12秒前
gaowei完成签到,获得积分10
13秒前
瑞_完成签到,获得积分10
15秒前
16秒前
高分求助中
Sustainability in Tides Chemistry 1500
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
CLSI EP47 Evaluation of Reagent Carryover Effects on Test Results, 1st Edition 800
Threaded Harmony: A Sustainable Approach to Fashion 799
Livre et militantisme : La Cité éditeur 1958-1967 500
Retention of title in secured transactions law from a creditor's perspective: A comparative analysis of selected (non-)functional approaches 500
"Sixth plenary session of the Eighth Central Committee of the Communist Party of China" 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3055112
求助须知:如何正确求助?哪些是违规求助? 2711905
关于积分的说明 7428965
捐赠科研通 2356735
什么是DOI,文献DOI怎么找? 1248250
科研通“疑难数据库(出版商)”最低求助积分说明 606641
版权声明 596083